APA (7th ed.) Citation

GM, K., KH, J., HC, J., J, L., KS, L., SA, I., . . . J, S. (2026). A randomized phase III trial of anthracyclines followed by taxane versus taxane plus carboplatin as (neo)adjuvant therapy in patients with triple-negative breast cancer: KCSG BR 15-1 PEARLY trial. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2026.05.703

Chicago Style (17th ed.) Citation

GM, Kim, et al. "A Randomized Phase III Trial of Anthracyclines Followed by Taxane Versus Taxane Plus Carboplatin as (neo)adjuvant Therapy in Patients with Triple-negative Breast Cancer: KCSG BR 15-1 PEARLY Trial." Annals of Oncology : Official Journal of the European Society for Medical Oncology 2026. https://doi.org/10.1016/j.annonc.2026.05.703.

MLA (9th ed.) Citation

GM, Kim, et al. "A Randomized Phase III Trial of Anthracyclines Followed by Taxane Versus Taxane Plus Carboplatin as (neo)adjuvant Therapy in Patients with Triple-negative Breast Cancer: KCSG BR 15-1 PEARLY Trial." Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2026, https://doi.org/10.1016/j.annonc.2026.05.703.